IMMUNITYBIO, INC. (IBRX) Net income 2016–2025
IMMUNITYBIO, INC. (IBRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$351.5MFY2025 · since FY2016: -$120.8M → -$351.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$351.5M | +15.0% |
| FY2024 | -$413.6M | +29.2% |
| FY2023 | -$583.9M | -39.9% |
| FY2022 | -$417.3M | -19.3% |
| FY2021 | -$349.8M | -57.7% |
| FY2020 | -$221.9M | -40.6% |
| FY2019 | -$157.8M | -64.0% |
| FY2018 | -$96.2M | +0.2% |
| FY2017 | -$96.4M | +20.2% |
| FY2016 | -$120.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice